YOLFTbeta
Anhui Huaheng Biotechnology Co. Ltd. A

Anhui Huaheng Biotechnology Co. Ltd. A

688639 · SHG · Healthcare / Biotechnology

15.61CNY-0.47 (-2.92%)

Price History

Full chart

Market Stats

Previous Close16.08
Open16.17
Day Range15.58 – 16.35
52-Week Range14.52 – 43.35
Volume4.95M
Market Cap4.78B
P/E (TTM)40.66
Forward P/E0.00
EPS0.47
Dividend Yield0.84%
Beta0.15
50-Day Avg17.16
200-Day Avg25.83

About

Anhui Huaheng Biotechnology Co., Ltd. engages in the research and development, production, and sale of bio-based products through bio-manufacturing in China and internationally. The company offers amino acid products, including the alanine series, L-valine, isoleucine, tryptophan, and arginine; vitamin products, such as D-calcium pantothenate, D-panthenol, and inositol; bio-based new material monomers, including 1,3-propanediol and succinic acid; and other products, including malic acid and arbutin. Its products are used in daily chemical products, medicine, health and personal care products, cosmetic products, food additives, feeds, animal nutrition, plant nutrition, and functional food and nutrition. The company was formerly known as Anhui Huaheng Biological Engineering Co., Ltd. and changed its name to Anhui Huaheng Biotechnology Co., Ltd. in November 2013. The company was founded in 2005 and is based in Hefei, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMs. Henghua Guo
  • Employees2.25K
  • HeadquartersNo. 197, Chuangxin Avenue and Chang'an Road, Hefei, China, 231031, China
  • Websitehttps://www.huahengbio.com

Leadership

  • Ms. Henghua GuoChairman of the Board & GM · b. 1964
  • Mr. Yi FanCFO, Deputy GM & Director · b. 1977
  • Mr. Xueli ZhangDirector & Core Technical Personnel · b. 1981
  • Mr. Jian Wen MaoDeputy GM & Director · b. 1964
  • Mr. Dongzhu ZhangDeputy GM & Director · b. 1973
  • Mr. Zhong Cheng LiuDeputy General Manager · b. 1972
  • Xiu Fa ZhuAccounting Supervisor
  • Mr. Xian He DengBoard Secretary · b. 1989
  • Mr. Siqing TangCore technical personnel · b. 1982
  • Mr. Liu LeiCore technical personnel · b. 1987

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue86.68M173.40M224.87M253.47M311.40M382.55M420.85M491.31M487.24M954.10M1.42B1.94B2.18B2.86B
Growth (%)-+100.05%+29.68%+12.72%+22.85%+22.85%+10.01%+16.74%-0.83%+95.81%+48.69%+36.63%+12.37%+31.40%
Cost of Revenue75.57M133.24M151.30M169.85M193.31M249.91M253.73M265.62M289.40M646.00M870.26M1.16B1.64B2.25B
Gross Profit11.11M40.16M73.57M83.62M118.09M132.64M167.11M225.69M197.85M308.10M548.39M782.37M539.66M608.62M
Gross Margin12.82%23.16%32.72%32.99%37.92%34.67%39.71%45.94%40.61%32.29%38.66%40.36%24.78%21.27%
Operating Expense11.58M28.03M51.42M37.68M50.08M59.67M82.65M79.72M65.49M121.75M206.35M271.47M340.34M478.97M
Operating Income-472.12K12.13M22.15M45.94M68.01M72.97M84.47M145.97M132.36M186.34M342.04M510.90M199.32M129.65M
Operating Margin-0.54%7.00%9.85%18.12%21.84%19.08%20.07%29.71%27.16%19.53%24.11%26.36%9.15%4.53%
EBITDA-1.20M27.62M38.13M59.10M85.25M101.04M115.56M183.07M177.81M239.94M402.67M618.31M381.09M384.19M
EBITDA Margin-1.38%15.93%16.96%23.32%27.38%26.41%27.46%37.26%36.49%25.15%28.38%31.90%17.50%13.42%
Net Income-3.80M13.00M22.99M42.80M61.79M64.89M75.51M126.38M121.10M168.24M320.03M449.06M189.52M132.41M
Net Income Margin-4.38%7.50%10.22%16.89%19.84%16.96%17.94%25.72%24.85%17.63%22.56%23.17%8.70%4.63%
R&D-6.26M---19.84M21.73M29.95M30.12M52.84M78.61M108.82M124.05M151.20M
R&D as % of Total Revenue-3.61%---5.19%5.16%6.10%6.18%5.54%5.54%5.61%5.70%5.28%
Interest Expense-9.10M4.69M1.58M-6.22M4.73M4.15M2.83M1.65M540.25K13.20M41.03M47.52M
Interest Expense % of Total Revenue-5.25%2.09%0.62%-1.63%1.12%0.84%0.58%0.17%0.04%0.68%1.88%1.66%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets125.90M184.98M189.91M289.20M386.04M412.06M541.13M561.09M742.89M1.47B2.03B3.97B4.99B5.77B
Total Liabilities118.10M164.52M135.81M174.73M209.78M201.33M230.84M192.41M253.11M290.98M545.44M2.14B2.43B3.14B
Total Equity7.80M20.46M54.10M114.46M176.26M210.73M310.29M368.68M489.78M1.18B1.48B1.83B2.56B2.65B
Cash27.78M28.84M24.03M41.30M53.10M24.08M62.11M54.50M62.20M121.79M147.46M352.98M422.64M284.12M
Total Debt69.00M60.00M67.33M106.66M120.00M85.00M100.00M65.09M55.07M18.50M79.23M1.22B1.32B2.10B
Net Debt41.22M31.16M43.30M65.36M66.90M60.92M37.89M10.59M-7.13M-103.29M-68.24M867.07M897.15M1.82B

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-6.76M41.21M30.56M35.27M55.02M105.69M89.31M181.48M109.57M95.70M357.43M304.28M199.79M104.55M
Investing Cash Flow5.01M-45.35M-7.01M-72.23M-58.51M-47.08M-63.76M-79.86M-73.81M-511.82M-342.00M-1.13B-930.09M-643.46M
Financing Cash Flow575.08K4.20M-13.26M52.78M6.73M-68.23M5.04M-108.89M-21.07M476.98M6.46M1.02B780.75M409.22M
Capital Expenditure7.95M22.50M19.43M90.13M58.84M48.03M63.40M81.73M72.64M180.63M456.35M1.27B923.51M636.73M
Free Cash Flow-14.71M18.70M11.12M-54.86M-3.82M57.66M25.91M99.75M36.93M-84.93M-98.92M-967.75M-723.72M-532.18M
Dividends Paid5.39M6.32M20.11M35.41M8.13M31.70M4.63M74.60M2.86M36.40M59.73M97.56M183.41M110.81M
FCF to OCF217.70%45.39%36.40%-155.55%-6.94%54.56%29.01%54.96%33.71%-88.74%-27.68%-318.05%-362.23%-509.03%
Dividend Paid to FCF-36.63%33.79%180.84%-64.54%-212.88%54.98%17.89%74.79%7.73%-42.85%-60.38%-10.08%-25.34%-20.82%

Earnings

Report DateOct 27, 2021Feb 22, 2022Apr 29, 2022Aug 17, 2022Oct 27, 2022Apr 25, 2023Aug 28, 2023Oct 25, 2023Feb 23, 2024Apr 21, 2024Aug 27, 2024Oct 28, 2024Feb 25, 2025Apr 22, 2025Aug 27, 2025Sep 30, 2025Mar 17, 2026Apr 22, 2026
EPS Estimate------0.630.490.760.540.610.720.270.270.400.440.020.25
EPS Actual0.370.680.510.680.800.950.700.540.830.380.390.080.120.040.260.21-0.140.17
Surprise------11.11%10.20%9.21%-29.63%-36.07%-88.89%-55.56%-85.19%-35.00%-52.33%-800.00%-32.00%
TimingPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-market-After-hoursPre-market

Key Statistics & Ratios

Market Cap4.78B
Enterprise Value6.53B
Trailing P/E40.66
Forward P/E0.00
Price / Sales1.59
Price / Book1.69
EPS0.47
Book Value10.55
Revenue (TTM)3.00B
Gross Profit (TTM)621.84M
EBITDA414.84M
Profit Margin3.94%
Operating Margin8.01%
Return on Equity3.87%
Return on Assets1.59%
Shares Outstanding250.12M
Shares Float162.75M
Beta0.15
Dividend Yield0.84%
Dividend Rate0.16
Payout Ratio66.67%

Dividends

20261×
0.16May 12, 2026
20251×
0.25Jul 10, 2025
20241×
0.90Jul 22, 2024
20231×
0.62May 31, 2023
20221×
0.26Jul 19, 2022
20211×
0.16Jun 30, 2021

Stock Splits

  • Jul 22, 20241.45:1
  • May 31, 20231.45:1